Lifestyle drugs: Pharmacology and the social agenda

Trends in Pharmacological Sciences

Volumn 25, Issue 4, 2004, Pages 182-185

  Flower, Rod ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMFEBUTAMONE; ASCORBIC ACID; ATROPA BELLADONNA EXTRACT; CAFFEINE; CANNABIS; CARISOPRODOL; COCA EXTRACT; COCAINE; DESIGNER DRUG; ERYTHROPOIETIN; FINASTERIDE; FISH OIL; HERBACEOUS AGENT; ILLICIT DRUG; METHADONE; MINOXIDIL; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PHYSOSTIGMA VENOSUM EXTRACT; SIBUTRAMINE; SILDENAFIL; STEROID; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ALOPECIA; ATROPA BELLADONNA; DOCTOR PATIENT RELATION; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG USE; HEALTH CARE SYSTEM; HUMAN; LIFESTYLE; MEDICINAL PLANT; MENTAL CAPACITY; MYASTHENIA GRAVIS; NEUROPATHIC PAIN; PHYSICAL CAPACITY; PHYSOSTIGMA VENOSUM; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SELF EVALUATION; SELF MEDICATION; SOCIAL ASPECT; SOCIAL PHOBIA;

EID: 1942421733     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.02.006     Document Type: Article

References (29)

1. Atkinson T. Lifestyle drug market booming. Nat. Med. 8:2002;909.
2. Bogdanovic S., Langlands B. Lifestyle drugs patient-initiated prescribing. Biophoenix. 2001;. http://www.biophoenix.com.
3. Research and Markets Ltd (1999) Lifestyle drugs outlook to 2005. Research and Markets ( http://www.researchandmarkets.com ).
4. Gilbert D., et al. Lifestyle medicines. Br. Med. J. 321:2000;1341-1344.
5. Gilbert, D. (1999) Lifestyle drugs: Who will pay? In Scrip Report, PJB Publications.
6. Young S.N. Lifestyle drugs, mood, behaviour and cognition. J. Psychiatry Neurosci. 28:2003;87-89.
7. Moffat A. Do we need drugs for pleasure? Pharm. J. 265:2000;373.
8. Kole P.L., et al. Lifestyle drugs: new avenues. Express Healthcare Management. 2003;. 1 February.
9. Smith R. In search of 'non-disease'. Br. Med. J. 324:2002;883-885.
10. Lexchin J. Lifestyle drugs: issues for debate. CMAJ. 164:2001;1449-1451.
11. Moynihan R. The making of a disease: female sexual dysfunction. Br. Med. J. 326:2003;45-47.
12. Webber J., et al. The new era of lifestyle drugs. Business Week. 1998;. 11 May.
13. Boseley S. Anti-obesity drug given licence for NHS use. The Guardian. 2001;. 10 March.
14. Etienne G., et al. Imatinib mesylate and gray hair. New Engl. J. Med. 347:2002;446.
15. Templeton S. Pill to cure shopping disorder fuels fears over lifestyle drugs. Sunday Herald. 2002;. 22 July.
16. Cochrane K. Thrusting young men. The new Viagra addicts. The Times. 2003;. 31 August.
17. Barnett A. Deadly cost of the trade in online prescription drugs. The Observer. 2003;. 10 August.
18. Everitt D.E., et al. Clinical decision-making in the evaluation and treatment of insomnia. Am. J. Med. 89:1990;357-362.
19. Walley T. Lifestyle medicines and the elderly. Drugs Aging. 19:2002;163-168.
20. Weatherall M. In Search of a Cure. 1990;Oxford University Press.
21. Young E. Cannabis drugs pass testing 'milestone'. New Scientist. 2002;. 5 November.
22. Hall, C. (1998) Viagra abuse 'will add £1bn to NHS bill' Daily Telegraph, 8 July.
23. Butler P. NHS overspent on impotence drugs. The Guardian. 2000;. 11 December.
24. Winyard, G. (1998) Prescribing of Sildenafil (Viagra), Department of Health ( http://www.doh.gov.uk ).
25. Reuters Health Information (2002) UK health agency asks for 'citizen council' for input, Reuters ( http://www.reutershealth.com ).
26. Butler P. Don't let the hypocrites decide. The Guardian. 2000;. 12 December.
27. Kane P. Lifestyle drugs. The Herald. 1998;. 24 September.
28. Knight J. Agony for researchers as mix-up forces retraction of ecstasy study. Nature. 425:2003;109.
29. Huxley A. Brave New World. 1932;Chatto and Windus.